Vaccines (Development)

FDA Licenses Expanded Use for Inactivated Polio Vaccine

Published in Vaccine Weekly, April 14th, 1997

The U.S. Food and Drug Administration (FDA) has licensed the expanded use of IPOL Poliovirus Vaccine Inactivated (an enhanced, inactivated polio vaccine or eIPV, to include routine vaccination as part of an all-eIPV or a sequential schedule for all U.S. children.

The expanded use supports recommendations published by the U.S. Centers for Disease Control and Prevention (CDC) on January 24, 1997. The purpose of the change in the CDC's polio policy is to help reduce the incidence of disease associated with the live-virus, oral polio vaccine (OPV). There are 8-10 such cases reported each year in the U.S. The CDC's recommendations are due to be implemented during the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1997-04-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry